$54.24 -0.20 (-0.37%)
12/3/2009 4:00 PM

Abbott Laboratories (ABT)

CAPS Rating: 5 out of 5

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

Recs

1
Member Avatar Shaftsbury (65.71) Submitted: 1/21/2009 6:03:05 PM : Outperform Start Price: $50.33 ABT Score: -28.51

This equity has been relatively flat of late compared to its peers, but has significantly outperformed the market over the past year. With an excellent earning report today and a very nice forecast for 2009, expect the stock to move higher, or at worst, to outperform in a bad market.

Report this Post 0 Comments

Featured Broker Partners